Dr. Knost is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
8940 N Wood Sage Rd
Peoria, IL 61615Phone(309) 243-3000
Fax(309) 243-3050- Is this information wrong?
Education & Training
Vanderbilt UniversityFellowship, Medical Oncology, 1979 - 1980
Vanderbilt UniversityResidency, Internal Medicine, 1974 - 1977
Louisiana State University School of Medicine in New OrleansClass of 1974
Certifications & Licensure
CA State Medical License 2017 - 2020
WY State Medical License 2016 - 2018
CO State Medical License 2016 - 2017
IL State Medical License 1992 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
Clinical Trials
- Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 2 - Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib Including Tumors With Mutations or Translocations of FGFR, PDGFR, VEGF, cKIT Start of enrollment: 2013 Aug 01Groves, M.D.,Dhillon, N.,Santala, R.G.,Shimkus, B.J.,Thompson, M.A.,Cohn, A.L.,Hermann, R.C.,Larson, T.G.,Spigel, D.R.,Boyd, T.E.,Chawla, S.P.,Nikolinakos, P.G.,Taylor, M.H.,Blau, S.,Palchak, D.L.,Spitz, ...
- Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 1 - BKM120 for Patients With PI3K-activated Tumors Start of enrollment: 2013 Mar 01Beck, J.M.,Wade, J.L.,Demetri, G.D.,Sohal, D.P.,Savin, M.A.,Buscema, J.,Dhillon, N.,Thambi, P.M.,Hurwitz, H.,Yardley, D.A.,Richards, D.A.,Nikolinakos, P.G.,Vaena, D.A.,Grilley-Olson, J.E.,Schwartzberg, L....
Publications & Presentations
PubMed
- MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Can...Aparna Raj Parikh, Fa-Chyi Lee, Linda Yau, Han Koh, James A. Knost, Edith P. Mitchell, Ivan Bosanac, Nicholas Choong, Frank A. Scappaticci, Christoph Mancao, Heinz-Jos...> ;Clinical Cancer Research. 2019 May 15
- Clinical Germline Diagnostic Exome Sequencing for Hereditary Cancer: Findings Within Novel Candidate Genes Are PrevalentZöe Powis, Carin R. Espenschied, Holly LaDuca, Kelly D. Farwell Hagman, Tripti Paudyal, Shuwei Li, Hiroto Inaba, Ann Mauer, Katherine L. Nathanson, James Knost, Elizab...> ;Cancer Genetics and Cytogenetics. 2018 Aug 1
- Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic...Alexa B. Schrock, Shuyu D. Li, Garrett M. Frampton, James Suh, Eduardo Braun, Ranee Mehra, Steven C. Buck, Jose A. Bufill, Nir Peled, Nagla Abdel Karim, K. Cynthia Hsi...> ;Journal of Thoracic Oncology. 2017 Jun 1
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- UnityPoint Health - PeoriaPeoria, Illinois
- UnityPoint Health - ProctorPeoria, Illinois
- St. Margaret's HospitalSpring Valley, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
